Your browser doesn't support javascript.
loading
Sirolimus in Advanced Epithelioid Hemangioendothelioma: A Retrospective Case-Series Analysis from the Italian Rare Cancer Network Database.
Stacchiotti, Silvia; Provenzano, Salvatore; Dagrada, Gianpaolo; Negri, Tiziana; Brich, Silvia; Basso, Umberto; Brunello, Antonella; Grosso, Federica; Galli, Luca; Palassini, Elena; Libertini, Michela; Colia, Vittoria; Gronchi, Alessandro; Dei Tos, Angelo P; Crippa, Flavio; Morosi, Carlo; Pilotti, Silvana; Casali, Paolo G.
Afiliación
  • Stacchiotti S; Medical Oncology Unit 2 - Adult Mesenchymal Tumours and Rare Cancers, Department of Cancer Medicine, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy. silvia.stacchiotti@istitutotumori.mi.it.
  • Provenzano S; Medical Oncology Unit 2 - Adult Mesenchymal Tumours and Rare Cancers, Department of Cancer Medicine, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
  • Dagrada G; Experimental Molecular Pathology Unit, Department of Pathology, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
  • Negri T; Experimental Molecular Pathology Unit, Department of Pathology, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
  • Brich S; Experimental Molecular Pathology Unit, Department of Pathology, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
  • Basso U; Medical Oncology Unit 1, Department of Clinical and Experimental Oncology, Istituto Oncologico Veneto IOV IRCCS, Padua, Italy.
  • Brunello A; Medical Oncology Unit 1, Department of Clinical and Experimental Oncology, Istituto Oncologico Veneto IOV IRCCS, Padua, Italy.
  • Grosso F; Oncology, SS Antonio e Biagio General Hospital, Alessandria, Italy.
  • Galli L; Oncology, Santa Chiara Hospital, Pisa, Italy.
  • Palassini E; Medical Oncology Unit 2 - Adult Mesenchymal Tumours and Rare Cancers, Department of Cancer Medicine, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
  • Libertini M; Medical Oncology Unit 2 - Adult Mesenchymal Tumours and Rare Cancers, Department of Cancer Medicine, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
  • Colia V; Medical Oncology Unit 2 - Adult Mesenchymal Tumours and Rare Cancers, Department of Cancer Medicine, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
  • Gronchi A; Department of Surgery, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
  • Dei Tos AP; Department of Anatomic Pathology, General Hospital of Treviso, Treviso, Italy.
  • Crippa F; Department of Nuclear Medicine, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
  • Morosi C; Department of Radiology, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
  • Pilotti S; Experimental Molecular Pathology Unit, Department of Pathology, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
  • Casali PG; Medical Oncology Unit 2 - Adult Mesenchymal Tumours and Rare Cancers, Department of Cancer Medicine, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
Ann Surg Oncol ; 23(9): 2735-44, 2016 09.
Article en En | MEDLINE | ID: mdl-27334221
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Hemangioendotelioma Epitelioide / Sirolimus / Péptidos y Proteínas de Señalización Intracelular / Antibióticos Antineoplásicos Tipo de estudio: Observational_studies / Prognostic_studies Límite: Adult / Aged / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Año: 2016 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Hemangioendotelioma Epitelioide / Sirolimus / Péptidos y Proteínas de Señalización Intracelular / Antibióticos Antineoplásicos Tipo de estudio: Observational_studies / Prognostic_studies Límite: Adult / Aged / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Año: 2016 Tipo del documento: Article